LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Elenco Azioni・Abbott Laboratories

Search

Abbott Laboratories

Chiusa

SettoreSettore sanitario

90.7 4.07

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

87.01

Massimo

91.41

Metriche Chiave
By Trading Economics
Entrata	-699M 1.1B
Vendite	-295M 11B
P/E Media del settore	24.588 49.888
EPS	1.15
Rendimento da dividendi	2.85
Margine di Profitto	9.647
Dipendenti	122,000
EBITDA	-980M 1.8B

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+31.92% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	2.85% 2.38%
Utili prossimi	16 lug 2026
Prossima data del Dividendo	14 ago 2026
Prossima data del' Ex Dividendo	14 lug 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-22B 153B
Apertura precedente	86.63
Chiusura precedente	90.7

Notizie sul Sentiment di mercato

By Acuity

28%

72%

66 / 344 Classifica in Healthcare

Abbott Laboratories Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

3 giu 2026, 13:49 UTC

Utili

I principali Market Mover

MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion

16 apr 2026, 15:13 UTC

Utili

I principali Market Mover

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt 1Q Sales -- Update

16 apr 2026, 12:23 UTC

Utili

I principali Market Mover

Abbott Laboratories Cuts Outlook, Narrows 1Q Profit

22 gen 2026, 18:36 UTC

Utili

I principali Market Mover

Abbott Laboratories Raised Prices, Prompting Sales Slump -- Update

16 apr 2026, 20:23 UTC

Utili

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 16:15 UTC

Utili

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

16 apr 2026, 14:00 UTC

Discorsi di Mercato

Utili

A Mild Flu Season Hurt Abbott's Recent Quarter -- Market Talk

16 apr 2026, 13:59 UTC

Discorsi di Mercato

Utili

Abbott Laboratories Has Disappointing Quarter -- Market Talk

16 apr 2026, 12:05 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. -- Barrons.com

16 apr 2026, 11:32 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs: 2026 EPS View Includes 20c Dilution Related to Exact Sciences Buy >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees 2Q Adj EPS $1.25-Adj EPS $1.31 >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees 2026 Comparable Sales Growth of 6.5%-7.5% >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs Updates Guidance to Reflect Acquisition of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Sales $11.16B >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Reports First-Quarter 2026 Results; Updates Guidance To Reflect Acquisition Of Exact Sciences >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Net $1.08B >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q Adj EPS $1.15 >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs Sees FY Adj EPS $5.38-Adj EPS $5.58 >ABT

16 apr 2026, 11:30 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Abbott Labs 1Q EPS 61c >ABT

11 apr 2026, 00:00 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Big Yachts, Big Bucks -- Barrons.com

23 mar 2026, 12:50 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Completes Acquisition Of Exact Sciences >ABT

20 mar 2026, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Labs: Received All Regulatory Clearances for Exact Sciences Buy >ABT EXAS

20 mar 2026, 13:00 UTC

Acquisizioni, Fusioni, Takeovers

Abbott Acquisition Of Exact Sciences Set To Close On March 23, 2026 >ABT

28 gen 2026, 14:48 UTC

Utili

Abbott Stock Fell the Most in 23 Years After Earnings. The CEO Bought $2 Million of Shares. -- Barrons.com

23 gen 2026, 16:59 UTC

Utili

Correction to Abbott Stock Drops Article on Jan. 22

22 gen 2026, 20:42 UTC

Utili

Abbott Stock Is on Pace for Worst Day Since 2000. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 gen 2026, 16:19 UTC

Utili

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings. -- Barrons.com

22 gen 2026, 15:22 UTC

Utili

Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes -- WSJ

22 gen 2026, 14:41 UTC

Azioni calde

Stocks to Watch Thursday: Intel, P&G, GE Aerospace -- WSJ

22 gen 2026, 14:08 UTC

Discorsi di Mercato

Utili

Abbott Posts Disappointing 4Q -- Market Talk

Confronto tra pari

Modifica del prezzo

Abbott Laboratories Previsione

Obiettivo di Prezzo

By TipRanks

31.92% in crescita

Previsioni per 12 mesi

Media 119.76 USD 31.92%

Alto 143 USD

Basso 92 USD

Basato su 20 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Abbott Laboratories - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

20 ratings

16

Acquista

4

Mantieni

0

Vendi

Basato sugli analisti di 20 che hanno fornito valutazioni azionarie a Abbott Laboratories - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

66 / 344 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Altri titoli del settore

LLY

Eli Lilly and Co.

1,125.18

JNJ

Johnson and Johnson

228.23

ABBV

AbbVie Inc

224.88

UNH

UnitedHealth Group Inc

396.79

MRK

Merck & Co Inc.

120.25

Live chat